Clinical Trials Logo

Clinical Trial Details — Status: Enrolling by invitation

Administrative data

NCT number NCT02682966
Other study ID # DEPICT-NCS
Secondary ID
Status Enrolling by invitation
Phase N/A
First received February 3, 2016
Last updated November 14, 2017
Start date September 2016
Est. completion date December 2020

Study information

Verified date November 2017
Source UMC Utrecht
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This is a prospective study in patients who undergo routine postoperative troponin assessment after major (semi-)elective noncardiac surgery. Two groups are created based on postoperative troponin levels: Postoperative myocardial injury (PMI) group with troponin I levels ≥ 60 ng/L and a control group with troponin levels < 60ng/L. The primary aim of this study is to assess the association of PMI with pulmonary embolism. Additionally, the association between PMI and obstructive CAD will be investigated.


Recruitment information / eligibility

Status Enrolling by invitation
Enrollment 354
Est. completion date December 2020
Est. primary completion date December 2019
Accepts healthy volunteers No
Gender All
Age group 60 Years and older
Eligibility Inclusion Criteria:

- = 60 years old

- Major noncardiac surgery, defined as non-cardiac surgical procedures requiring hospital admittance > 24 hours

- Semi-elective surgery, defined as surgery that that has been preceded by a preoperative evaluation.

- = 1 troponin assessment in the first 3 postoperative days as a part of the routine 'postoperative troponin assessment' protocol.

- For patients who undergo surgery more than once, the first surgery will be included in the analysis. Reoperations will not be included.

Exclusion Criteria:

- Typical anginal complaints

- Acute ST-elevation myocardial infarction (STEMI) or new left bundle branch block (LBBB) on ECG

- Patients unable to fully comply to study needs (e.g. incompetent patients or patients unable to communicate in Dutch or English)

- Severe claustrophobia.

- Patients who have a life expectancy of less than three months.

- Patients who are too ill to undergo a CCTA or Ventilation/Perfusion (V/Q) scan.

Study Design


Related Conditions & MeSH terms


Intervention

Radiation:
Coronary Computed Tomography Angiography
Coronary Computed Tomography Angiography will be performed in all participants

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
UMC Utrecht

Outcome

Type Measure Description Time frame Safety issue
Primary Pulmonary Embolism Pulmonary embolism (PE) on either Coronary Computed Tomography Angiography (CCTA) or Ventilation/Perfusion (V/Q) scan. PE on CCTA is defined as a sharply delineated pulmonary artery filling defect in at least two consecutive image sections of the CCTA, either located centrally within the vessel or with acute angles at its interface with the vessel wall. PE on V/Q scan is defined as at least one segmental or two subsegmental perfusion defects without corresponding abnormality on chest X-ray. 1 week
Secondary Obstructive coronary artery disease > 50% stenosis in one or more epicardial vessels on CCTA 1 week
Secondary Obstructive main stem or proximal left anterior descending (LAD) stenosis Incidence of obstructive (>50%) main stem or proximal left anterior descending (LAD) stenosis 1 week
Secondary 30-day MACE Major adverse cardiovascular events within 30 postoperative days, which is defined as the composite of cardiovascular death, non-fatal myocardial infarction, non-fatal cardiac arrest, non-fatal ventricular fibrillation and ventricular arrhythmia with hemodynamic compromise. 30 days
Secondary 30-day all-cause mortality 30-day
Secondary major diagnostic changes Major Diagnostic change, which is defined as a clinically relevant change in diagnosis after CCTA in comparison to the most likely diagnosis before CCTA. The diagnosis prior to CCTA is made by the cardiology consultant and is based on routine clinical 1 week
Secondary major therapeutic changes Major Therapeutic change, which is defined as any change in in management of patients due to CCTA findings compared to the proposed treatment before CCTA 1 week
Secondary bleeding bleeding within one year after surgery, which is based on TIMI criteria 1 year after surgery